Thus, in a manner similar to the AIRE mutation that limits expression of self-antigens in the thymus, this genetic risk variant may act by specifically impeding the expression of pro-insulin in the thymus resulting in a tissue-specific failure of central tolerance which can contribute to the development of pathogenic proinsulin-specific T cells and ultimately the development of T1D. Here, INS is linked to type 1 diabetes mellitus.